Pharmaceutical

AbbVie and Richter partner for neuropsychiatric treatments

AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

Oct 26, 2024 - 04:00
AbbVie and Richter partner for neuropsychiatric treatments
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
Read the original article

Tags:

Previous Article

Takeda and BMC partner to decarbonise US healthcare sector

Next Article

US CDC AdCom recommends lowering the age for pneumococcal vaccines

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: One Duchenne patient’s bittersweet hope for new treatment

Listen: One Duchenne patient’s bittersweet hope for new...

Jul 12, 2023

US PTO voids Seagen’s ADC patent infringement claims against Daiichi

US PTO voids Seagen’s ADC patent infringement claims ag...

Jan 17, 2024

No more cookies: How healthcare companies can gain trust for data consent

No more cookies: How healthcare companies can gain trus...

Sep 15, 2023